Lemaitre Vascular (LMAT) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Price: $87.92 +9.08%
Financial Fact:
Foreign currency gain (loss): -61K
Today's EPS Names:
CIX, ARIS, COHR, More
Financial Fact:
Foreign currency gain (loss): -61K
Today's EPS Names:
CIX, ARIS, COHR, More
Join SI Premium – FREE
Lemaitre Vascular (NASDAQ: LMAT) reported Q2 EPS of $0.43, $0.01 better than the analyst estimate of $0.42.
For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lemaitre Vascular (LMAT) Misses Q3 EPS by 4c ; Offers Guidance
- Viemed Healthcare, Inc. (VMD) Misses Q3 EPS by 2c; updates guidance
- Innoviva (INVA) Misses Q3 EPS by 156c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
